Ilsung Is Co., Ltd. (KRX:003120)
18,600
-490 (-2.57%)
At close: Jun 4, 2026
Ilsung Is Revenue
Ilsung Is had revenue of 16.71B KRW in the quarter ending March 31, 2026, with 0.53% growth. This brings the company's revenue in the last twelve months to 64.38B, down -7.57% year-over-year. In the year 2025, Ilsung Is had annual revenue of 64.29B, down -6.85%.
Revenue (ttm)
64.38B
Revenue Growth
-7.57%
P/S Ratio
2.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
133.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 64.29B | -4.73B | -6.85% |
| Dec 31, 2024 | 69.02B | -9.03B | -11.58% |
| Dec 31, 2023 | 78.05B | 16.81B | 27.44% |
| Dec 31, 2022 | 61.25B | 19.16B | 45.52% |
| Dec 31, 2021 | 42.09B | 1.49B | 3.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 625.97B |
| Jeil Pharmaceutical Co.,Ltd | 534.52B |
| Dongwha Pharm.Co.,Ltd | 501.33B |
| Ilyang Pharmaceutical Co.,Ltd | 275.51B |
| Kyongbo Pharmaceutical | 269.64B |
| HLB Pharmaceutical | 236.59B |
| Daihan Pharmaceutical | 211.44B |
| Samil Pharmaceutical Co.,Ltd | 210.51B |